Effect of specimen anticoagulation on the measurement of circulating platelet-derived growth factors.
Zimmermann R, Koenig J, Zingsem J, Weisbach V, Strasser E, Ringwald J, Eckstein R
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of type of anticoagulant on spontaneous and induced Plt activation and the release of GFs from Plts.
Summary of Findings
When CTAD was used as an anticoagulant, ADP- induced Plt activation and spontaneous expression of CD62 were lower compared to sodium citrate or K3EDTA blood or serum. In addition, CTAD plasma had the lowest concentrations of PDGF-AB, TGF-beta1, VEGF, and bFGF compared to the other 3 types of specimens. Serum contained the highest concentrations of all four GFs, and K3EDTA plasma showed high interindividual variability. The authors recommend the use of CTAD blood when measuring circulating GFs released from Plts.
Biospecimens
FluidBloodFluidPlasmaFluidSerumPreservation Types
None (Fresh)Diagnoses
NormalPlatforms
Cell count/volumeFlow cytometryCell count/volumeHematology/ auto analyzerProteinHematology/ auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant Citrate-theophylline-adenosine-dipyridamoleNonePotassium EDTASodium citrateBiospecimen Aliquots and Components Blood and blood products PlasmaSerumWhole bloodHematology/ auto analyzer Specific Reaction solution ADPCollagenRistocetinHematology/ auto analyzer Specific Targeted peptide/protein PDGF-ABTGF-beta1VEGFbFGF